Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer

Cancer Immunity

Volumn 3, Issue , 2003, Pages 1-11

  Zhang, Huiming ^a   Melamed, Jonathan ^b   Wei, Ping ^a   Cox, Karen ^a   Frankel, Wendy ^a   Bahnson, Robert R ^a   Robinson, Nikki ^a   Pyka, Ron ^c   Liu, Yang ^a   Zheng, Pan ^a,d  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c Riverside Hospital   (United States)

^d 129 Hamilton Hall ^*  (United States)

Author keywords

Human; Immunohistochemistry; MHC class I; PML; Prostate cancer

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROMYELOCYTIC LEUKEMIA PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CANCER GRADING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOWN REGULATION; GENE EXPRESSION; GENE REPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTO ONCOGENE;

EID: 3042701410     PISSN: 14249634     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Greenberg PD. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. Adv Immunol 1991; 49: 281-355. (PMID: 1853786)
2. Ramarathinam L, Castle M, Wu Y, Liu Y. T cell costimulation by B7/BB1 induces CD8 T cell-dependent tumor rejection: an important role of B7/BB1 in the induction, recruitment, and effector function of antitumor T cells. J Exp Med 1994; 179: 1205-1214. (PMID: 7511683)
3. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. The foreign antigen binding site and T cell recognition region of class I histocompatibility antigens. Nature 1987; 329: 512-518. (PMID: 2443855)
4. van den Broek ME, Kagi D, Ossendorp F, Toes R, Vamvakas S, Lutz WK, Melief CJ, Zinkernagel RM, Hengartner H. Decreased tumor surveillance in perforin-deficient mice. J Exp Med 1996; 184: 1781-1790. (PMID: 8920866)
5. Pardoll DM. Cancer vaccines. Nat Med 1998; 4: 525-531. (PMID: 9585204)
6. Boon T, Cerottini JC, Van den Eynde B, van der Bruggen P, Van Pel A. Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 1994; 12: 337-365. (PMID: 8011285)
7. Liu Y, Linsley PS. Costimulation of T-cell growth. Curr Opin Immunol 1992; 4: 265-270. (PMID: 1418704)
8. Chen L, Ashe S, Brady WA, Hellstrom I, Hellstrom KE, Ledbetter JA, McGowan P, Linsley PS. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4. Cell 1992; 71: 1093-1102. (PMID: 1335364)
9. Chen L, Linsley PS, Hellstrom KE. Costimulation of T cells for tumor immunity. Immunol Today 1993; 14: 483-486. (PMID: 7506034)
10. Ferrone S, Marincola FM. Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance. Immunol Today 1995; 16: 487-494. (PMID: 7576053)
11. Doyle A, Martin WJ, Funa K, Gazdar A, Carney D, Martin SE, Linnoila I, Cuttitta F, Mulshine J, Bunn P, Minna J. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med 1985; 161: 1135-1151. (PMID: 2580935)
12. Concha A, Esteban F, Cabrera T, Ruiz-Cabello F, Garrido F. Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer. Semin Cancer Biol 1991; 2: 47-54. (PMID: 2580935)
13. Concha A, Cabrera T, Ruiz-Cabello F, Garrido F. Can the HLA phenotype be used as a prognostic factor in breast carcinomas? Int J Cancer Suppl 1991; 6: 146-154. (PMID: 2066180)
14. Blades RA, Keating PJ, McWilliam LJ, George NJ, Stern PL. Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology 1995; 46: 681-686; discussion 686-687. (PMID: 7495121)
15. Sharpe JC, Abel PD, Gilbertson JA, Brawn P, Foster CS. Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastic and malignant human prostatic epithelium. Br J Urol 1994; 74: 609-616. (PMID: 7530126)
16. Zheng P, Guo Y, Niu Q, Levy DE, Dyck JA, Lu S, Sheiman LA, Liu Y. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature 1998; 396: 373-376. (PMID: 9845074)
17. Martinez CK, Monaco JJ. Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene. Nature 1991; 353: 664-667. (PMID: 1681432)
18. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A. Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters. Nature 1990; 348: 741-744. (PMID: 2259383)
19. Spies T, Bresnahan M, Bahram S, Arnold D, Blanck G, Mellins E, Pious D, DeMars R. A gene in the human major histocompatibility complex class II region controlling the class I antigen-presentation pathway. Nature 1990; 348: 744-747. (PMID: 2259384)
20. Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity 1996; 5: 103-114. (PMID: 8769474)
21. Seliger B, Ritz U, Abele R, Bock M, Tampe R, Sutter G, Drexler I, Huber C, Ferrone S. Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. Cancer Res 2001; 61: 8647-8650. (PMID: 11751378)
22. Wang Z, Cao Y, Albino AP, Zeff RA, Houghton A, Ferrone S. Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by reading-frameshift in beta 2-microglobulin messenger RNA. J Clin Invest 1993; 91: 684-692. (PMID: 8432869)
23. Chen HL, Gabrilovich D, Tampe R, Girgis KR, Nadaf S, Carbone DP. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer [see comments]. Nat Genet 1996; 13: 210-213. (PMID: 8640228)
24. Franksson L, George E, Powis S, Butcher G, Howard J, Karre K. Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene. J Exp Med 1993; 177: 201-205. (PMID: 8418201)
25. Korkolopoulou P, Kaklamanis L, Pezzella F, Harris AL, Gatter KC. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer. Br J Cancer 1996; 73: 148-153. (PMID: 8546899)
26. Restifo NP, Esquivel F, Asher AL, Stotter H, Barth RJ, Bennink JR, Mule JJ, Yewdell JW, Rosenberg SA. Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response. J Immunol 1991; 147: 1453-1459. (PMID: 1907999)
27. Vegh Z, Wang P, Vanky F, Klein E. Selective down-regulated expression of major histocompatibility complex class I alleles in human solid tumors. Cancer Res 1993; 53(10 Suppl): 2416-2420. (PMID: 8485728)
28. Shiels C, Islam SA, Vatcheva R, Sasieni P, Sternberg MJ, Freemont PS, Sheer D. PML bodies associate specifically with the MHC gene cluster in interphase nuclei. J Cell Sci 2001; 114(Pt 20): 3705-3716. (PMID: 11707522)
29. Chang SK, Park B, Shin J, Ahn JH, Kim IH, Ahn K. Proto-oncogene PML enhances antigen presentation by MHC class I molecules in human lung cancer cells. Mol Cells 2002; 14: 130-135. (PMID: 12243342)
30. Bruno S, Ghiotto F, Fais F, Fagioli M, Luzi L, Pelicci PG, Grossi CE, Ciccone E. The PML gene is not involved in the regulation of MHC class I expression in human cell lines. Blood 2002 [epub ahead of print]. (PMID: 12506025)
31. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL. HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 1990; 2: 113-125. (PMID: 2088481)
32. Zheng P, Sarma S, Guo Y, Liu Y. Two mechanisms for tumor evasion of preexisting cytotoxic T-cell responses: lessons from recurrent tumors. Cancer Res 1999; 59: 3461-3467. (PMID: 10416611)
33. Dyck JA, Maul GG, Miller WH Jr, Chen JD, Kakizuka A, Evans RM. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994; 76: 333-343. (PMID: 8293467)
34. Koken MH, Linares-Cruz G, Quignon F, Viron A, Chelbi-Alix MK, Sobczak-Thepot J, Juhlin L, Degos L, Calvo F, de The H. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene 1995; 10: 1315-1324. (PMID: 7731682)
35. Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncini L, Bigerna B, Pacini R, Tanci LN, Pasqualucci L, Ascani S, Mencarelli A, Liso A, Pelicci PG, Falini B. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am J Pathol 1996; 149: 2023-2035. (PMID: 8952536)
36. Garrido F, Cabrera T, Lopez-Nevot MA, Ruiz-Cabello F. HLA class I antigens in human tumors. Adv Cancer Res 1995; 67: 155-195. (PMID: 8571814)